Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Assets: 2020-2025

Historic Assets for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $43.9 million.

  • Insight Molecular Diagnostics' Assets fell 37.43% to $43.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.9 million, marking a year-over-year decrease of 37.43%. This contributed to the annual value of $35.1 million for FY2024, which is 53.16% down from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Assets is $43.9 million, which was down 13.03% from $50.5 million recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Assets peaked at $177.4 million during Q2 2021, and registered a low of $35.1 million during Q4 2024.
  • In the last 3 years, Insight Molecular Diagnostics' Assets had a median value of $70.6 million in 2024 and averaged $65.0 million.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Assets surged by 191.37% in 2021 and then crashed by 53.16% in 2024.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Assets stood at $159.6 million in 2021, then slumped by 37.27% to $100.1 million in 2022, then declined by 25.18% to $74.9 million in 2023, then slumped by 53.16% to $35.1 million in 2024, then slumped by 37.43% to $43.9 million in 2025.
  • Its last three reported values are $43.9 million in Q3 2025, $50.5 million for Q2 2025, and $60.4 million during Q1 2025.